搜索临床试验以:amendement du facteur C5 du complément
总计371377个结果
-
University of CincinnatiUniversity of Colorado, Denver; Children's Hospital Medical Center, Cincinnati完全的
-
University of PennsylvaniaNational Heart, Lung, and Blood Institute (NHLBI); GlaxoSmithKline完全的
-
National Heart, Lung, and Blood Institute (NHLBI)完全的心脏疾病 | 心血管疾病 | 动脉粥样硬化 | 冠状动脉硬化
-
National Heart, Lung, and Blood Institute (NHLBI)完全的
-
Centre Hospitalier Universitaire Vaudois完全的
-
AOP Orphan Pharmaceuticals AGPharmaEssentia Corporation (Co-Sponsor for USA)完全的
-
Heart Force Medical Inc.完全的
-
Japan Blood Products Organization完全的
-
Posit Science CorporationUniversity of California, San Francisco; Case Western Reserve University撤销
-
Fundación para la Investigación del Hospital Clínico...Ministerio de Sanidad, Servicios Sociales e Igualdad完全的
-
Astellas Pharma IncAstellas Pharma Taiwan, Inc.完全的
-
University of Wisconsin, MadisonOcean Spray Cranberries, Inc.完全的
-
Centre Hospitalier Universitaire VaudoisGlaxoSmithKline; University of Lausanne; University of Lausanne Hospitals; World Health Organization 和其他合作者完全的
-
Helsinn Healthcare SA完全的
-
Dompé Farmaceutici S.p.A完全的
-
Logan University, Inc.Sport and Spine Rehab Clinical Research Foundation; Parker University; Brentwood Spine Clinic,...终止
-
Beijing Center for Disease Control and PreventionBeijing Minhai Biotechnology Co., Ltd完全的健康 | 狂犬病
-
University of CincinnatiGenzyme, a Sanofi Company; Millennium Pharmaceuticals, Inc.完全的
-
Beijing Chaoyang District Centre for Disease Control...完全的
-
Beijing Center for Disease Control and PreventionBeijing Minhai Biotechnology Co., Ltd完全的安全性、免疫原性
-
University of PittsburghNational Cancer Institute (NCI)完全的
-
Mount Sinai Hospital, Canada完全的